GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 729 filers reported holding GLAXOSMITHKLINE PLC in Q1 2016. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,999,000 | -0.1% | 45,921 | -0.0% | 0.36% | +12.6% |
| Q1 2022 | $2,001,000 | -12.4% | 45,941 | -11.3% | 0.32% | -10.7% |
| Q4 2021 | $2,284,000 | +15.1% | 51,801 | -0.3% | 0.36% | +5.7% |
| Q3 2021 | $1,984,000 | -4.8% | 51,936 | -0.8% | 0.34% | -2.6% |
| Q2 2021 | $2,084,000 | +7.3% | 52,336 | -3.8% | 0.34% | +3.3% |
| Q1 2021 | $1,942,000 | -6.0% | 54,406 | -3.0% | 0.33% | -12.8% |
| Q4 2020 | $2,065,000 | -2.5% | 56,106 | -0.2% | 0.38% | -13.5% |
| Q3 2020 | $2,117,000 | -8.2% | 56,246 | -0.5% | 0.44% | -13.0% |
| Q2 2020 | $2,307,000 | +8.1% | 56,546 | +0.3% | 0.51% | -4.5% |
| Q1 2020 | $2,135,000 | -20.2% | 56,351 | -1.1% | 0.53% | +7.0% |
| Q4 2019 | $2,676,000 | +9.4% | 56,951 | -0.6% | 0.50% | +1.2% |
| Q3 2019 | $2,445,000 | +2.5% | 57,276 | -3.9% | 0.49% | +3.4% |
| Q2 2019 | $2,386,000 | -7.9% | 59,616 | -3.8% | 0.48% | -10.5% |
| Q1 2019 | $2,590,000 | +10.1% | 61,982 | +0.6% | 0.53% | +1.5% |
| Q4 2018 | $2,353,000 | -5.8% | 61,582 | -0.9% | 0.52% | +11.3% |
| Q3 2018 | $2,497,000 | -1.3% | 62,172 | -1.0% | 0.47% | -6.9% |
| Q2 2018 | $2,530,000 | -22.5% | 62,772 | -24.9% | 0.51% | -22.6% |
| Q1 2018 | $3,265,000 | +7.0% | 83,572 | -2.8% | 0.65% | +11.8% |
| Q4 2017 | $3,051,000 | -13.0% | 86,022 | -0.4% | 0.58% | -17.8% |
| Q3 2017 | $3,507,000 | -6.4% | 86,372 | -0.6% | 0.71% | -7.0% |
| Q2 2017 | $3,748,000 | +0.9% | 86,909 | -1.4% | 0.77% | -1.5% |
| Q1 2017 | $3,716,000 | +8.1% | 88,147 | -1.2% | 0.78% | +4.1% |
| Q4 2016 | $3,437,000 | -24.7% | 89,247 | -15.6% | 0.75% | -26.8% |
| Q3 2016 | $4,562,000 | -4.9% | 105,772 | -4.5% | 1.02% | -7.1% |
| Q2 2016 | $4,799,000 | +6.4% | 110,732 | -0.5% | 1.10% | +2.8% |
| Q1 2016 | $4,512,000 | -17.8% | 111,282 | -18.2% | 1.07% | -14.1% |
| Q4 2015 | $5,489,000 | -3.9% | 136,032 | -8.4% | 1.24% | -6.7% |
| Q3 2015 | $5,710,000 | -6.4% | 148,507 | +1.4% | 1.33% | +5.0% |
| Q2 2015 | $6,101,000 | -2.2% | 146,482 | +8.4% | 1.27% | +0.8% |
| Q1 2015 | $6,237,000 | +5.2% | 135,157 | -2.5% | 1.26% | +6.5% |
| Q4 2014 | $5,928,000 | -3.4% | 138,693 | +3.9% | 1.18% | -7.4% |
| Q3 2014 | $6,138,000 | +5.7% | 133,518 | +22.9% | 1.28% | +7.6% |
| Q2 2014 | $5,809,000 | -0.4% | 108,620 | -0.5% | 1.19% | -4.4% |
| Q1 2014 | $5,833,000 | -2.6% | 109,170 | -2.7% | 1.24% | -1.3% |
| Q4 2013 | $5,989,000 | +5.9% | 112,170 | -0.5% | 1.26% | -3.8% |
| Q3 2013 | $5,655,000 | +0.3% | 112,720 | -0.1% | 1.31% | -4.0% |
| Q2 2013 | $5,640,000 | – | 112,870 | – | 1.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |